Gujarat Themis Biosyn Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 396.54 million compared to INR 476.91 million a year ago. Revenue was INR 406.54 million compared to INR 490.87 million a year ago. Net income was INR 125.43 million compared to INR 186.99 million a year ago. Basic earnings per share from continuing operations was INR 1.726 compared to INR 2.574 a year ago.
For the six months, sales was INR 892.42 million compared to INR 926.35 million a year ago. Revenue was INR 913.17 million compared to INR 954.54 million a year ago. Net income was INR 302.65 million compared to INR 364.69 million a year ago. Basic earnings per share from continuing operations was INR 4.166 compared to INR 5.02 a year ago.